参考文献/References:
[1]杨保华,刘亚玲,李小敏,等.临床护理路径在冠心病心绞痛患者护理中的临床应用效果[J].实用中西医结合临床,2017,17(5):138-139.[2]郭续彩,鞠秀君.临床护理路径在冠心病心绞痛患者中的应用[J].中国医药指南,2017,15(3):210.[3]杨媛媛.临床护理路径在冠心病心绞痛患者护理中的应用效果研究[J].护士进修杂志,2016,22(7):143-144.[4]魏亚.预见性护理在冠心病心绞痛患者护理中的应用分析[J].中国医药导刊,2016,18(10):1056-1057.[5]马洪宇,王爱红.中医临床护理路径联合胸痹贴干预冠心病心绞痛疗效及对患者满意度影响[J].长春中医药大学学报,2016,32(4):762-764.[6]唐兴凤.临床护理路径在不稳定性心绞痛患者介入治疗中应用效果分析[J].当代医学,2016,22(11):111-112.[7]许辉,罗桂梅.临床护理路径信息系统在不稳定性心绞痛行PCI术患者中的应用[J].中国数字医学,2019,14(6):37-39.[8]姚旭琴.临床护理路径在心绞痛患者护理中的应用效果探究[J].中国药物与临床,2018,18(12):2269-2270.[9]Hou JK,Gashe C,Drazin NZ,et al.Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases[J].Inflamm Bowel Dis,2017,23(1):35-43.[10]谌昆.临床护理路径对冠心病心绞痛患者的影响效果分析[J].吉林医学,2016,37(7):1822-1823.[11]赵莉华.冠心病心绞痛患者接受临床护理路径干预的效果分析[J].国际护理学杂志,2016,3(13):72-73.[12]胡燕,李晓芳.临床护理路径在冠心病心绞痛患者护理中的应用效果研究[J].中国医药指南,2016,14(26):239.[13]陈倩.临床护理路径在冠心病心绞痛60例中的应用[J].中国民族民间医药,2016,25(12):165-166.[14]王珊芝.临床护理路径及心血管药物治疗用于冠心病心绞痛患者的临床价值[J].临床合理用药杂志,2019,12(35):114-115.[15]卓儒红,姚红艳.临床护理路径用于冠心病介入治疗护理中的效果评价[J].现代中西医结合杂志,2019,28(7):780-783.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(19):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(19):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(19):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(19):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[5]詹 红.儿童哮喘临床护理路径变异相关因素的Logstic回归分析[J].医学信息,2018,31(07):175.[doi:10.3969/j.issn.1006-1959.2018.07.062]
ZHAN Hong.Logstic Regression Analysis of Variation Related Factors of Clinical Nursing Path in Children with Asthma[J].Medical Information,2018,31(19):175.[doi:10.3969/j.issn.1006-1959.2018.07.062]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(19):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(19):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(19):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(19):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(19):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[11]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(19):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]